scispace - formally typeset
M

Moses R. Kamya

Researcher at Makerere University

Publications -  504
Citations -  15407

Moses R. Kamya is an academic researcher from Makerere University. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 60, co-authored 435 publications receiving 12598 citations. Previous affiliations of Moses R. Kamya include Mulago Hospital.

Papers
More filters
Journal ArticleDOI

Lopinavir/Ritonavir-Based Antiretroviral Treatment (ART) Versus Efavirenz-Based ART for the Prevention of Malaria Among HIV-Infected Pregnant Women

TL;DR: Lopinavir/ritonavir-based ART did not reduce the risk of placental or maternal malaria or improve birth outcomes, compared with efavirenz-based Art, and there were no differences in secondary outcomes between the 2 treatment arms.
Journal ArticleDOI

Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.

TL;DR: A significant portion of HIV-infected African children experience EVF that would be undetected using CD4/clinical monitoring and resulted in the accumulation of ARV mutations that could compromise second-line therapy options.
Journal ArticleDOI

Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda.

TL;DR: To improve capacity for malaria microscopy in Uganda, a 3-day refresher training program was conducted in four districts, with a significant impact on the knowledge of staff, accuracy of microscopy, and quality of blood-slide preparation.
Journal ArticleDOI

Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda.

TL;DR: This work estimated the association between distance to clinic and other transportation‐related barriers on pre‐exposure prophylaxis (PrEP) uptake and initial clinic visit attendance in a rural community in southwestern Uganda enrolled in the ongoing SEARCH study.
Journal ArticleDOI

Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study

TL;DR: Routine screening of a targeted group of HIV patients may enable early detection of cryptococcal infection and intervention before initiating antiretroviral therapy, and hence provide an opportunity for early intervention.